Davidson Kempner Capital Management LP Merck & Co., Inc. Transaction History

Davidson Kempner Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $1.34 Million - $1.49 Million	18,700 Added 7.99%	252,635 $20.7 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $5.73 Million - $6.5 Million	78,335 Added 50.34%	233,935 $18.5 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $3.46 Million - $4.8 Million	54,668 Added 54.16%	155,600 $12 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $5.99 Million - $6.75 Million	77,150 Added 324.41%	100,932 $8.76 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $1.81 Million - $1.97 Million	23,782 New	23,782 $2 Million

3,953

1.94B

16M

15M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $222B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Davidson Kempner Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Davidson Kempner Capital Management LP with notifications on news.